OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
156559

St.Shine Optical Co Ltd

Medical Equipment, Supplies & DistributionVerified

St.Shine Optical maintains a strong liquidity position with a current ratio of 3.87 and cash and equivalents of TWD 1,182,006,000, indicating robust short-term financial flexibility. The company's debt-to-equity ratio of 0.05 suggests a conservative capital structure with minimal leverage, supporting financial stability. Free cash flow of TWD 133,223,000 and operating cash flow of TWD 592,160,000 further reinforce its ability to fund operations and reinvest without external financing. Profitability metrics show a return on equity (ROE) of 6.95% and a return on assets (ROA) of 5.83%, which are in line with industry norms for medical equipment and supplies firms. The company's operating margin of 12.76% (calculated from operating income of TWD 525,174,000 on revenue of TWD 4,116,858,000) reflects efficient cost management and pricing power in its core markets. Geographically, St.Shine Optical operates in both domestic and international markets, though the financial snapshot does not provide a breakdown of revenue by region. The absence of segment-specific data limits the ability to assess geographic concentration risk, but the company's global sales strategy suggests diversification. The company's revenue growth trajectory is not explicitly provided in the input data, but the consistent operating cash flow and positive free cash flow suggest stable operations. Analysts have assigned a mean price target of TWD 145.00, with a median and high target also at TWD 145.00, indicating a consensus on valuation. Risk factors for St.Shine Optical are currently low, with no immediate liquidity or dilution flags detected. The company's low debt levels and strong cash position reduce exposure to interest rate fluctuations and refinancing risk. Additionally, the absence of dilution risk and the conservative capital structure support long-term stability. Recent events and filings do not indicate any material changes in the company's operations or strategic direction. The lack of strong-buy analyst ratings and the presence of one buy and two hold recommendations suggest a cautious outlook from the investment community, though the consensus price target implies confidence in the company's intrinsic value.

30-day price · 1565-10.90 (-10.4%)
Low$93.50High$109.50Close$93.60As of15 May, 00:00 UTC
Profile
CompanySt.Shine Optical Co Ltd
Ticker1565.TWO
SectorHealthcare
BusinessHealthcare Services & Equipment
Industry groupHealthcare Services & Equipment
IndustryMedical Equipment, Supplies & Distribution
AI analysis

Business. St.Shine Optical Co Ltd is a Taiwan-based company engaged in the manufacture and sale of disposable contact lenses, primarily utilizing hydrophilic soft materials and injection molding techniques to produce a wide range of lenses with varying water content and structures.

Classification. St.Shine Optical is classified under the Healthcare sector, specifically in the Medical Equipment, Supplies & Distribution industry, with a confidence level of 0.92 based on verified market data.

St.Shine Optical maintains a strong liquidity position with a current ratio of 3.87 and cash and equivalents of TWD 1,182,006,000, indicating robust short-term financial flexibility. The company's debt-to-equity ratio of 0.05 suggests a conservative capital structure with minimal leverage, supporting financial stability. Free cash flow of TWD 133,223,000 and operating cash flow of TWD 592,160,000 further reinforce its ability to fund operations and reinvest without external financing. Profitability metrics show a return on equity (ROE) of 6.95% and a return on assets (ROA) of 5.83%, which are in line with industry norms for medical equipment and supplies firms. The company's operating margin of 12.76% (calculated from operating income of TWD 525,174,000 on revenue of TWD 4,116,858,000) reflects efficient cost management and pricing power in its core markets. Geographically, St.Shine Optical operates in both domestic and international markets, though the financial snapshot does not provide a breakdown of revenue by region. The absence of segment-specific data limits the ability to assess geographic concentration risk, but the company's global sales strategy suggests diversification. The company's revenue growth trajectory is not explicitly provided in the input data, but the consistent operating cash flow and positive free cash flow suggest stable operations. Analysts have assigned a mean price target of TWD 145.00, with a median and high target also at TWD 145.00, indicating a consensus on valuation. Risk factors for St.Shine Optical are currently low, with no immediate liquidity or dilution flags detected. The company's low debt levels and strong cash position reduce exposure to interest rate fluctuations and refinancing risk. Additionally, the absence of dilution risk and the conservative capital structure support long-term stability. Recent events and filings do not indicate any material changes in the company's operations or strategic direction. The lack of strong-buy analyst ratings and the presence of one buy and two hold recommendations suggest a cautious outlook from the investment community, though the consensus price target implies confidence in the company's intrinsic value.
Key takeaways
  • St.Shine Optical maintains a conservative capital structure with a low debt-to-equity ratio of 0.05 and strong liquidity.
  • The company's ROE of 6.95% and ROA of 5.83% align with industry norms, indicating solid profitability.
  • Analysts have assigned a consensus price target of TWD 145.00, with a median and high target also at TWD 145.00.
  • The company's low risk profile, with no immediate liquidity or dilution flags, supports long-term stability.
  • St.Shine Optical's global sales strategy suggests geographic diversification, though segment-specific data is not provided.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyTWD
Revenue$4.12B
Gross profit$949.7M
Operating income$525.2M
Net income$455.0M
R&D
SG&A
D&A
SBC
Operating cash flow$592.2M
CapEx-$84.2M
Free cash flow$133.2M
Total assets$7.81B
Total liabilities$1.26B
Total equity$6.55B
Cash & equivalents$1.18B
Long-term debt$301.4M
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$6.55B
Net cash$880.6M
Current ratio3.9
Debt/Equity0.1
ROA5.8%
ROE7.0%
Cash conversion1.3%
CapEx/Revenue-2.0%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskLow
  • No immediate filing-based liquidity or dilution flags were detected.
Industry benchmarks
Activity: Healthcare Services & Equipment · cohort 5 companies
Metric1565Activity
Op margin12.8%13.3% medp25 5.9% · p75 13.5%below median
Net margin11.1%8.6% medp25 2.7% · p75 12.7%above median
Gross margin23.1%64.0% medp25 60.1% · p75 65.6%bottom quartile
R&D / revenue6.9% medp25 6.7% · p75 7.1%
CapEx / revenue-2.0%3.0% medp25 2.7% · p75 4.5%bottom quartile
Debt / equity5.0%69.3% medp25 63.4% · p75 74.5%bottom quartile
Observations
IR observations
Mean price target145.00 TWD
Median price target145.00 TWD
High price target145.00 TWD
Low price target145.00 TWD
Mean recommendation2.67 (1=strong buy, 5=strong sell)
Strong-buy count0.00
Buy count1.00
Hold count2.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate9.40 TWD
Last actual EPS8.91 TWD
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod financials
no public URL
2026-05-15 14:36 UTC#02fad504
Source: analysis-pipeline (hybrid)Generated: 2026-05-15 14:40 UTCJob: 1f1400b7